1 End-Stage Renal Disease (ESRD) Device Market Overview
    1.1 Product Overview and Scope of End-Stage Renal Disease (ESRD) Device
    1.2 End-Stage Renal Disease (ESRD) Device Segment by Type
        1.2.1 Global End-Stage Renal Disease (ESRD) Device Sales Growth Rate Comparison by Type (2022-2028)
        1.2.2 Hemodialysis
        1.2.3 Peritoneal Dialysis
        1.2.4 Kidney Transplantation
    1.3 End-Stage Renal Disease (ESRD) Device Segment by Application
        1.3.1 Global End-Stage Renal Disease (ESRD) Device Sales Comparison by Application: (2022-2028)
        1.3.2 Public Hospitals
        1.3.3 Private Hospitals
        1.3.4 Medical Research Center
        1.3.5 Others
    1.4 Global End-Stage Renal Disease (ESRD) Device Market Size Estimates and Forecasts
        1.4.1 Global End-Stage Renal Disease (ESRD) Device Revenue 2017-2028
        1.4.2 Global End-Stage Renal Disease (ESRD) Device Sales 2017-2028
        1.4.3 End-Stage Renal Disease (ESRD) Device Market Size by Region: 2017 Versus 2021 Versus 2028
2 End-Stage Renal Disease (ESRD) Device Market Competition by Manufacturers
    2.1 Global End-Stage Renal Disease (ESRD) Device Sales Market Share by Manufacturers (2017-2022)
    2.2 Global End-Stage Renal Disease (ESRD) Device Revenue Market Share by Manufacturers (2017-2022)
    2.3 Global End-Stage Renal Disease (ESRD) Device Average Price by Manufacturers (2017-2022)
    2.4 Manufacturers End-Stage Renal Disease (ESRD) Device Manufacturing Sites, Area Served, Product Type
    2.5 End-Stage Renal Disease (ESRD) Device Market Competitive Situation and Trends
        2.5.1 End-Stage Renal Disease (ESRD) Device Market Concentration Rate
        2.5.2 The Global Top 5 and Top 10 Largest End-Stage Renal Disease (ESRD) Device Players Market Share by Revenue
        2.5.3 Global End-Stage Renal Disease (ESRD) Device Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 End-Stage Renal Disease (ESRD) Device Retrospective Market Scenario by Region
    3.1 Global End-Stage Renal Disease (ESRD) Device Retrospective Market Scenario in Sales by Region: 2017-2022
    3.2 Global End-Stage Renal Disease (ESRD) Device Retrospective Market Scenario in Revenue by Region: 2017-2022
    3.3 North America End-Stage Renal Disease (ESRD) Device Market Facts & Figures by Country
        3.3.1 North America End-Stage Renal Disease (ESRD) Device Sales by Country
        3.3.2 North America End-Stage Renal Disease (ESRD) Device Revenue by Country
        3.3.3 United States
        3.3.4 Canada
    3.4 Europe End-Stage Renal Disease (ESRD) Device Market Facts & Figures by Country
        3.4.1 Europe End-Stage Renal Disease (ESRD) Device Sales by Country
        3.4.2 Europe End-Stage Renal Disease (ESRD) Device Revenue by Country
        3.4.3 Germany
        3.4.4 France
        3.4.5 U.K.
        3.4.6 Italy
        3.4.7 Russia
    3.5 Asia Pacific End-Stage Renal Disease (ESRD) Device Market Facts & Figures by Region
        3.5.1 Asia Pacific End-Stage Renal Disease (ESRD) Device Sales by Region
        3.5.2 Asia Pacific End-Stage Renal Disease (ESRD) Device Revenue by Region
        3.5.3 China
        3.5.4 Japan
        3.5.5 South Korea
        3.5.6 India
        3.5.7 Australia
        3.5.8 China Taiwan
        3.5.9 Indonesia
        3.5.10 Thailand
        3.5.11 Malaysia
    3.6 Latin America End-Stage Renal Disease (ESRD) Device Market Facts & Figures by Country
        3.6.1 Latin America End-Stage Renal Disease (ESRD) Device Sales by Country
        3.6.2 Latin America End-Stage Renal Disease (ESRD) Device Revenue by Country
        3.6.3 Mexico
        3.6.4 Brazil
        3.6.5 Argentina
        3.6.6 Colombia
    3.7 Middle East and Africa End-Stage Renal Disease (ESRD) Device Market Facts & Figures by Country
        3.7.1 Middle East and Africa End-Stage Renal Disease (ESRD) Device Sales by Country
        3.7.2 Middle East and Africa End-Stage Renal Disease (ESRD) Device Revenue by Country
        3.7.3 Turkey
        3.7.4 Saudi Arabia
        3.7.5 UAE
4 Global End-Stage Renal Disease (ESRD) Device Historic Market Analysis by Type
    4.1 Global End-Stage Renal Disease (ESRD) Device Sales Market Share by Type (2017-2022)
    4.2 Global End-Stage Renal Disease (ESRD) Device Revenue Market Share by Type (2017-2022)
    4.3 Global End-Stage Renal Disease (ESRD) Device Price by Type (2017-2022)
5 Global End-Stage Renal Disease (ESRD) Device Historic Market Analysis by Application
    5.1 Global End-Stage Renal Disease (ESRD) Device Sales Market Share by Application (2017-2022)
    5.2 Global End-Stage Renal Disease (ESRD) Device Revenue Market Share by Application (2017-2022)
    5.3 Global End-Stage Renal Disease (ESRD) Device Price by Application (2017-2022)
6 Key Companies Profiled
    6.1 Baxter
        6.1.1 Baxter Corporation Information
        6.1.2 Baxter Description and Business Overview
        6.1.3 Baxter End-Stage Renal Disease (ESRD) Device Sales, Revenue and Gross Margin (2017-2022)
        6.1.4 Baxter End-Stage Renal Disease (ESRD) Device Product Portfolio
        6.1.5 Baxter Recent Developments/Updates
    6.2 Medtronic
        6.2.1 Medtronic Corporation Information
        6.2.2 Medtronic Description and Business Overview
        6.2.3 Medtronic End-Stage Renal Disease (ESRD) Device Sales, Revenue and Gross Margin (2017-2022)
        6.2.4 Medtronic End-Stage Renal Disease (ESRD) Device Product Portfolio
        6.2.5 Medtronic Recent Developments/Updates
    6.3 Fresenius
        6.3.1 Fresenius Corporation Information
        6.3.2 Fresenius Description and Business Overview
        6.3.3 Fresenius End-Stage Renal Disease (ESRD) Device Sales, Revenue and Gross Margin (2017-2022)
        6.3.4 Fresenius End-Stage Renal Disease (ESRD) Device Product Portfolio
        6.3.5 Fresenius Recent Developments/Updates
    6.4 B. Braun
        6.4.1 B. Braun Corporation Information
        6.4.2 B. Braun Description and Business Overview
        6.4.3 B. Braun End-Stage Renal Disease (ESRD) Device Sales, Revenue and Gross Margin (2017-2022)
        6.4.4 B. Braun End-Stage Renal Disease (ESRD) Device Product Portfolio
        6.4.5 B. Braun Recent Developments/Updates
    6.5 Nikkiso
        6.5.1 Nikkiso Corporation Information
        6.5.2 Nikkiso Description and Business Overview
        6.5.3 Nikkiso End-Stage Renal Disease (ESRD) Device Sales, Revenue and Gross Margin (2017-2022)
        6.5.4 Nikkiso End-Stage Renal Disease (ESRD) Device Product Portfolio
        6.5.5 Nikkiso Recent Developments/Updates
    6.6 Toray
        6.6.1 Toray Corporation Information
        6.6.2 Toray Description and Business Overview
        6.6.3 Toray End-Stage Renal Disease (ESRD) Device Sales, Revenue and Gross Margin (2017-2022)
        6.6.4 Toray End-Stage Renal Disease (ESRD) Device Product Portfolio
        6.6.5 Toray Recent Developments/Updates
    6.7 Nipro
        6.6.1 Nipro Corporation Information
        6.6.2 Nipro Description and Business Overview
        6.6.3 Nipro End-Stage Renal Disease (ESRD) Device Sales, Revenue and Gross Margin (2017-2022)
        6.4.4 Nipro End-Stage Renal Disease (ESRD) Device Product Portfolio
        6.7.5 Nipro Recent Developments/Updates
    6.8 Asahi Kasei
        6.8.1 Asahi Kasei Corporation Information
        6.8.2 Asahi Kasei Description and Business Overview
        6.8.3 Asahi Kasei End-Stage Renal Disease (ESRD) Device Sales, Revenue and Gross Margin (2017-2022)
        6.8.4 Asahi Kasei End-Stage Renal Disease (ESRD) Device Product Portfolio
        6.8.5 Asahi Kasei Recent Developments/Updates
    6.9 Terumo
        6.9.1 Terumo Corporation Information
        6.9.2 Terumo Description and Business Overview
        6.9.3 Terumo End-Stage Renal Disease (ESRD) Device Sales, Revenue and Gross Margin (2017-2022)
        6.9.4 Terumo End-Stage Renal Disease (ESRD) Device Product Portfolio
        6.9.5 Terumo Recent Developments/Updates
    6.10 Newsol
        6.10.1 Newsol Corporation Information
        6.10.2 Newsol Description and Business Overview
        6.10.3 Newsol End-Stage Renal Disease (ESRD) Device Sales, Revenue and Gross Margin (2017-2022)
        6.10.4 Newsol End-Stage Renal Disease (ESRD) Device Product Portfolio
        6.10.5 Newsol Recent Developments/Updates
    6.11 Qingshan Likang
        6.11.1 Qingshan Likang Corporation Information
        6.11.2 Qingshan Likang End-Stage Renal Disease (ESRD) Device Description and Business Overview
        6.11.3 Qingshan Likang End-Stage Renal Disease (ESRD) Device Sales, Revenue and Gross Margin (2017-2022)
        6.11.4 Qingshan Likang End-Stage Renal Disease (ESRD) Device Product Portfolio
        6.11.5 Qingshan Likang Recent Developments/Updates
    6.12 WEGO
        6.12.1 WEGO Corporation Information
        6.12.2 WEGO End-Stage Renal Disease (ESRD) Device Description and Business Overview
        6.12.3 WEGO End-Stage Renal Disease (ESRD) Device Sales, Revenue and Gross Margin (2017-2022)
        6.12.4 WEGO End-Stage Renal Disease (ESRD) Device Product Portfolio
        6.12.5 WEGO Recent Developments/Updates
    6.13 Medionics
        6.13.1 Medionics Corporation Information
        6.13.2 Medionics End-Stage Renal Disease (ESRD) Device Description and Business Overview
        6.13.3 Medionics End-Stage Renal Disease (ESRD) Device Sales, Revenue and Gross Margin (2017-2022)
        6.13.4 Medionics End-Stage Renal Disease (ESRD) Device Product Portfolio
        6.13.5 Medionics Recent Developments/Updates
7 End-Stage Renal Disease (ESRD) Device Manufacturing Cost Analysis
    7.1 End-Stage Renal Disease (ESRD) Device Key Raw Materials Analysis
       7.1.1 Key Raw Materials
       7.1.2 Key Suppliers of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
    7.3 Manufacturing Process Analysis of End-Stage Renal Disease (ESRD) Device
    7.4 End-Stage Renal Disease (ESRD) Device Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
    8.1 Marketing Channel
    8.2 End-Stage Renal Disease (ESRD) Device Distributors List
    8.3 End-Stage Renal Disease (ESRD) Device Customers
9 End-Stage Renal Disease (ESRD) Device Market Dynamics
    9.1 End-Stage Renal Disease (ESRD) Device Industry Trends
    9.2 End-Stage Renal Disease (ESRD) Device Market Drivers
    9.3 End-Stage Renal Disease (ESRD) Device Market Challenges
    9.4 End-Stage Renal Disease (ESRD) Device Market Restraints
10 Global Market Forecast
    10.1 End-Stage Renal Disease (ESRD) Device Market Estimates and Projections by Type
        10.1.1 Global Forecasted Sales of End-Stage Renal Disease (ESRD) Device by Type (2023-2028)
        10.1.2 Global Forecasted Revenue of End-Stage Renal Disease (ESRD) Device by Type (2023-2028)
    10.2 End-Stage Renal Disease (ESRD) Device Market Estimates and Projections by Application
        10.2.1 Global Forecasted Sales of End-Stage Renal Disease (ESRD) Device by Application (2023-2028)
        10.2.2 Global Forecasted Revenue of End-Stage Renal Disease (ESRD) Device by Application (2023-2028)
    10.3 End-Stage Renal Disease (ESRD) Device Market Estimates and Projections by Region
        10.3.1 Global Forecasted Sales of End-Stage Renal Disease (ESRD) Device by Region (2023-2028)
        10.3.2 Global Forecasted Revenue of End-Stage Renal Disease (ESRD) Device by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
    12.1 Methodology/Research Approach
        12.1.1 Research Programs/Design
        12.1.2 Market Size Estimation
        12.1.3 Market Breakdown and Data Triangulation
    12.2 Data Source
        12.2.1 Secondary Sources
        12.2.2 Primary Sources
    12.3 Author List
    12.4 Disclaimer
                  
              

                

                 
List of Tables
    Table 1. Global End-Stage Renal Disease (ESRD) Device Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
    Table 2. Global End-Stage Renal Disease (ESRD) Device Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
    Table 3. Global End-Stage Renal Disease (ESRD) Device Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
    Table 4. Global End-Stage Renal Disease (ESRD) Device Market Competitive Situation by Manufacturers in 2021
    Table 5. Global End-Stage Renal Disease (ESRD) Device Sales (K Units) of Key Manufacturers (2017-2022)
    Table 6. Global End-Stage Renal Disease (ESRD) Device Sales Market Share by Manufacturers (2017-2022)
    Table 7. Global End-Stage Renal Disease (ESRD) Device Revenue (US$ Million) by Manufacturers (2017-2022)
    Table 8. Global End-Stage Renal Disease (ESRD) Device Revenue Share by Manufacturers (2017-2022)
    Table 9. Global Market End-Stage Renal Disease (ESRD) Device Average Price (US$/Unit) of Key Manufacturers (2017-2022)
    Table 10. Manufacturers End-Stage Renal Disease (ESRD) Device Manufacturing Sites and Area Served
    Table 11. Manufacturers End-Stage Renal Disease (ESRD) Device Product Type
    Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 13. Global End-Stage Renal Disease (ESRD) Device by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in End-Stage Renal Disease (ESRD) Device as of 2021)
    Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 15. Global End-Stage Renal Disease (ESRD) Device Sales by Region (2017-2022) & (K Units)
    Table 16. Global End-Stage Renal Disease (ESRD) Device Sales Market Share by Region (2017-2022)
    Table 17. Global End-Stage Renal Disease (ESRD) Device Revenue by Region (2017-2022) & (US$ Million)
    Table 18. Global End-Stage Renal Disease (ESRD) Device Revenue Market Share by Region (2017-2022)
    Table 19. North America End-Stage Renal Disease (ESRD) Device Sales by Country (2017-2022) & (K Units)
    Table 20. North America End-Stage Renal Disease (ESRD) Device Sales Market Share by Country (2017-2022)
    Table 21. North America End-Stage Renal Disease (ESRD) Device Revenue by Country (2017-2022) & (US$ Million)
    Table 22. North America End-Stage Renal Disease (ESRD) Device Revenue Market Share by Country (2017-2022)
    Table 23. Europe End-Stage Renal Disease (ESRD) Device Sales by Country (2017-2022) & (K Units)
    Table 24. Europe End-Stage Renal Disease (ESRD) Device Sales Market Share by Country (2017-2022)
    Table 25. Europe End-Stage Renal Disease (ESRD) Device Revenue by Country (2017-2022) & (US$ Million)
    Table 26. Europe End-Stage Renal Disease (ESRD) Device Revenue Market Share by Country (2017-2022)
    Table 27. Asia Pacific End-Stage Renal Disease (ESRD) Device Sales by Region (2017-2022) & (K Units)
    Table 28. Asia Pacific End-Stage Renal Disease (ESRD) Device Sales Market Share by Region (2017-2022)
    Table 29. Asia Pacific End-Stage Renal Disease (ESRD) Device Revenue by Region (2017-2022) & (US$ Million)
    Table 30. Asia Pacific End-Stage Renal Disease (ESRD) Device Revenue Market Share by Region (2017-2022)
    Table 31. Latin America End-Stage Renal Disease (ESRD) Device Sales by Country (2017-2022) & (K Units)
    Table 32. Latin America End-Stage Renal Disease (ESRD) Device Sales Market Share by Country (2017-2022)
    Table 33. Latin America End-Stage Renal Disease (ESRD) Device Revenue by Country (2017-2022) & (US$ Million)
    Table 34. Latin America End-Stage Renal Disease (ESRD) Device Revenue Market Share by Country (2017-2022)
    Table 35. Middle East and Africa End-Stage Renal Disease (ESRD) Device Sales by Country (2017-2022) & (K Units)
    Table 36. Middle East and Africa End-Stage Renal Disease (ESRD) Device Sales Market Share by Country (2017-2022)
    Table 37. Middle East and Africa End-Stage Renal Disease (ESRD) Device Revenue by Country (2017-2022) & (US$ Million)
    Table 38. Middle East and Africa End-Stage Renal Disease (ESRD) Device Revenue Market Share by Country (2017-2022)
    Table 39. Global End-Stage Renal Disease (ESRD) Device Sales by Type (2017-2022) & (K Units)
    Table 40. Global End-Stage Renal Disease (ESRD) Device Sales Market Share by Type (2017-2022)
    Table 41. Global End-Stage Renal Disease (ESRD) Device Revenue by Type (2017-2022) & (US$ Million)
    Table 42. Global End-Stage Renal Disease (ESRD) Device Revenue Share by Type (2017-2022)
    Table 43. Global End-Stage Renal Disease (ESRD) Device Price by Type (2017-2022) & (US$/Unit)
    Table 44. Global End-Stage Renal Disease (ESRD) Device Sales (K Units) by Application (2017-2022)
    Table 45. Global End-Stage Renal Disease (ESRD) Device Sales Market Share by Application (2017-2022)
    Table 46. Global End-Stage Renal Disease (ESRD) Device Revenue by Application (2017-2022) & (US$ Million)
    Table 47. Global End-Stage Renal Disease (ESRD) Device Revenue Share by Application (2017-2022)
    Table 48. Global End-Stage Renal Disease (ESRD) Device Price by Application (2017-2022) & (US$/Unit)
    Table 49. Baxter Corporation Information
    Table 50. Baxter Description and Business Overview
    Table 51. Baxter End-Stage Renal Disease (ESRD) Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 52. Baxter End-Stage Renal Disease (ESRD) Device Product
    Table 53. Baxter Recent Developments/Updates
    Table 54. Medtronic Corporation Information
    Table 55. Medtronic Description and Business Overview
    Table 56. Medtronic End-Stage Renal Disease (ESRD) Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 57. Medtronic End-Stage Renal Disease (ESRD) Device Product
    Table 58. Medtronic Recent Developments/Updates
    Table 59. Fresenius Corporation Information
    Table 60. Fresenius Description and Business Overview
    Table 61. Fresenius End-Stage Renal Disease (ESRD) Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 62. Fresenius End-Stage Renal Disease (ESRD) Device Product
    Table 63. Fresenius Recent Developments/Updates
    Table 64. B. Braun Corporation Information
    Table 65. B. Braun Description and Business Overview
    Table 66. B. Braun End-Stage Renal Disease (ESRD) Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 67. B. Braun End-Stage Renal Disease (ESRD) Device Product
    Table 68. B. Braun Recent Developments/Updates
    Table 69. Nikkiso Corporation Information
    Table 70. Nikkiso Description and Business Overview
    Table 71. Nikkiso End-Stage Renal Disease (ESRD) Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 72. Nikkiso End-Stage Renal Disease (ESRD) Device Product
    Table 73. Nikkiso Recent Developments/Updates
    Table 74. Toray Corporation Information
    Table 75. Toray Description and Business Overview
    Table 76. Toray End-Stage Renal Disease (ESRD) Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 77. Toray End-Stage Renal Disease (ESRD) Device Product
    Table 78. Toray Recent Developments/Updates
    Table 79. Nipro Corporation Information
    Table 80. Nipro Description and Business Overview
    Table 81. Nipro End-Stage Renal Disease (ESRD) Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 82. Nipro End-Stage Renal Disease (ESRD) Device Product
    Table 83. Nipro Recent Developments/Updates
    Table 84. Asahi Kasei Corporation Information
    Table 85. Asahi Kasei Description and Business Overview
    Table 86. Asahi Kasei End-Stage Renal Disease (ESRD) Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 87. Asahi Kasei End-Stage Renal Disease (ESRD) Device Product
    Table 88. Asahi Kasei Recent Developments/Updates
    Table 89. Terumo Corporation Information
    Table 90. Terumo Description and Business Overview
    Table 91. Terumo End-Stage Renal Disease (ESRD) Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 92. Terumo End-Stage Renal Disease (ESRD) Device Product
    Table 93. Terumo Recent Developments/Updates
    Table 94. Newsol Corporation Information
    Table 95. Newsol Description and Business Overview
    Table 96. Newsol End-Stage Renal Disease (ESRD) Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 97. Newsol End-Stage Renal Disease (ESRD) Device Product
    Table 98. Newsol Recent Developments/Updates
    Table 99. Qingshan Likang Corporation Information
    Table 100. Qingshan Likang Description and Business Overview
    Table 101. Qingshan Likang End-Stage Renal Disease (ESRD) Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 102. Qingshan Likang End-Stage Renal Disease (ESRD) Device Product
    Table 103. Qingshan Likang Recent Developments/Updates
    Table 104. WEGO Corporation Information
    Table 105. WEGO Description and Business Overview
    Table 106. WEGO End-Stage Renal Disease (ESRD) Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 107. WEGO End-Stage Renal Disease (ESRD) Device Product
    Table 108. WEGO Recent Developments/Updates
    Table 109. Medionics Corporation Information
    Table 110. Medionics Description and Business Overview
    Table 111. Medionics End-Stage Renal Disease (ESRD) Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 112. Medionics End-Stage Renal Disease (ESRD) Device Product
    Table 113. Medionics Recent Developments/Updates
    Table 114. Production Base and Market Concentration Rate of Raw Material
    Table 115. Key Suppliers of Raw Materials
    Table 116. End-Stage Renal Disease (ESRD) Device Distributors List
    Table 117. End-Stage Renal Disease (ESRD) Device Customers List
    Table 118. End-Stage Renal Disease (ESRD) Device Market Trends
    Table 119. End-Stage Renal Disease (ESRD) Device Market Drivers
    Table 120. End-Stage Renal Disease (ESRD) Device Market Challenges
    Table 121. End-Stage Renal Disease (ESRD) Device Market Restraints
    Table 122. Global End-Stage Renal Disease (ESRD) Device Sales Forecast by Type (2023-2028) & (K Units)
    Table 123. Global End-Stage Renal Disease (ESRD) Device Sales Market Share Forecast by Type (2023-2028)
    Table 124. Global End-Stage Renal Disease (ESRD) Device Revenue Forecast by Type (2023-2028) & (US$ Million)
    Table 125. Global End-Stage Renal Disease (ESRD) Device Revenue Market Share Forecast by Type (2023-2028)
    Table 126. Global End-Stage Renal Disease (ESRD) Device Sales Forecast by Application (2023-2028) & (K Units)
    Table 127. Global End-Stage Renal Disease (ESRD) Device Sales Market Share Forecast by Application (2023-2028)
    Table 128. Global End-Stage Renal Disease (ESRD) Device Revenue Forecast by Application (2023-2028) & (US$ Million)
    Table 129. Global End-Stage Renal Disease (ESRD) Device Revenue Market Share Forecast by Application (2023-2028)
    Table 130. Global End-Stage Renal Disease (ESRD) Device Sales Forecast by Region (2023-2028) & (K Units)
    Table 131. Global End-Stage Renal Disease (ESRD) Device Sales Market Share Forecast by Region (2023-2028)
    Table 132. Global End-Stage Renal Disease (ESRD) Device Revenue Forecast by Region (2023-2028) & (US$ Million)
    Table 133. Global End-Stage Renal Disease (ESRD) Device Revenue Market Share Forecast by Region (2023-2028)
    Table 134. Research Programs/Design for This Report
    Table 135. Key Data Information from Secondary Sources
    Table 136. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of End-Stage Renal Disease (ESRD) Device
    Figure 2. Global End-Stage Renal Disease (ESRD) Device Market Share by Type in 2021 & 2028
    Figure 3. Hemodialysis Product Picture
    Figure 4. Peritoneal Dialysis Product Picture
    Figure 5. Kidney Transplantation Product Picture
    Figure 6. Global End-Stage Renal Disease (ESRD) Device Market Share by Application in 2021 & 2028
    Figure 7. Public Hospitals
    Figure 8. Private Hospitals
    Figure 9. Medical Research Center
    Figure 10. Others
    Figure 11. Global End-Stage Renal Disease (ESRD) Device Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global End-Stage Renal Disease (ESRD) Device Market Size (2017-2028) & (US$ Million)
    Figure 13. Global End-Stage Renal Disease (ESRD) Device Sales (2017-2028) & (K Units)
    Figure 14. End-Stage Renal Disease (ESRD) Device Sales Share by Manufacturers in 2021
    Figure 15. Global End-Stage Renal Disease (ESRD) Device Revenue Share by Manufacturers in 2021
    Figure 16. The Global 5 and 10 Largest End-Stage Renal Disease (ESRD) Device Players: Market Share by Revenue in 2021
    Figure 17. End-Stage Renal Disease (ESRD) Device Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
    Figure 18. Global End-Stage Renal Disease (ESRD) Device Sales Market Share by Region (2017-2022)
    Figure 19. Global End-Stage Renal Disease (ESRD) Device Sales Market Share by Region in 2021
    Figure 20. Global End-Stage Renal Disease (ESRD) Device Revenue Market Share by Region (2017-2022)
    Figure 21. Global End-Stage Renal Disease (ESRD) Device Revenue Market Share by Region in 2021
    Figure 22. United States End-Stage Renal Disease (ESRD) Device Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 23. Canada End-Stage Renal Disease (ESRD) Device Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 24. Germany End-Stage Renal Disease (ESRD) Device Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 25. France End-Stage Renal Disease (ESRD) Device Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 26. U.K. End-Stage Renal Disease (ESRD) Device Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 27. Italy End-Stage Renal Disease (ESRD) Device Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 28. Russia End-Stage Renal Disease (ESRD) Device Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 29. China End-Stage Renal Disease (ESRD) Device Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 30. Japan End-Stage Renal Disease (ESRD) Device Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 31. South Korea End-Stage Renal Disease (ESRD) Device Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 32. India End-Stage Renal Disease (ESRD) Device Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 33. Australia End-Stage Renal Disease (ESRD) Device Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 34. China Taiwan End-Stage Renal Disease (ESRD) Device Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 35. Indonesia End-Stage Renal Disease (ESRD) Device Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 36. Thailand End-Stage Renal Disease (ESRD) Device Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 37. Malaysia End-Stage Renal Disease (ESRD) Device Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 38. Mexico End-Stage Renal Disease (ESRD) Device Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 39. Brazil End-Stage Renal Disease (ESRD) Device Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 40. Argentina End-Stage Renal Disease (ESRD) Device Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 41. Colombia End-Stage Renal Disease (ESRD) Device Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 42. Turkey End-Stage Renal Disease (ESRD) Device Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 43. Saudi Arabia End-Stage Renal Disease (ESRD) Device Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 44. UAE End-Stage Renal Disease (ESRD) Device Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 45. Sales Market Share of End-Stage Renal Disease (ESRD) Device by Type (2017-2022)
    Figure 46. Manufacturing Cost Structure of End-Stage Renal Disease (ESRD) Device
    Figure 47. Manufacturing Process Analysis of End-Stage Renal Disease (ESRD) Device
    Figure 48. End-Stage Renal Disease (ESRD) Device Industrial Chain Analysis
    Figure 49. Channels of Distribution
    Figure 50. Distributors Profiles
    Figure 51. Bottom-up and Top-down Approaches for This Report
    Figure 52. Data Triangulation
    Figure 53. Key Executives Interviewed